Switch to:
More From Other Websites
BioMarin CEO: Positive results for hemophilia treatment Jan 09 2017
BioMarin Pharma cites positive results for hemophilia treatment Jan 08 2017
BioMarin to Provide Update to Proof-of-Concept Data for BMN 270 Gene Therapy in Hemophilia A at 35th... Jan 08 2017
Could Sanofi Acquire BioMarin In Wake Of Amgen LDL Brouhaha? Jan 06 2017
Blog Coverage Affimed Join Hands with MD Anderson Cancer Center for Clinical Immuno-Oncology... Jan 05 2017
The Zacks Analyst Blog Highlights: Sucampo Pharmaceuticals, Dr. Reddy's Laboratories, BioMarin... Jan 04 2017
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bullish Manner : BMRN-US :... Jan 04 2017
3 Overlooked Drug Stocks to Watch Out for in 2017 Jan 03 2017
BioMarin to Present at 35th Annual J.P. Morgan Healthcare Conference in San Francisco Jan 03 2017
BioMarin (BMRN) Raised to Buy: Should You Add the Stock? Dec 29 2016
Time for biotech to boom ... or bust? Dec 27 2016
RBC Likes Large Cap Biotech Leaders for 2017 Dec 22 2016
BioMarin Pharmaceutical, Inc. – Value Analysis (NASDAQ:BMRN) : December 21, 2016 Dec 21 2016
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bearish Manner : BMRN-US :... Dec 20 2016
BIOMARIN PHARMACEUTICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Change... Dec 19 2016
Will Insurers Pay For Sarepta's DMD Drug? Dec 14 2016


No Entry for this criteria! We are updating our databases daily, please come back later!

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK